| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/29/2004 | CA2493067A1 Treatment of tnf.alpha. related disorders |
| 01/29/2004 | CA2492754A1 Compositions and products containing enantiomeric equol, and methods for their making |
| 01/29/2004 | CA2492651A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/28/2004 | EP1383787A2 Sapogenin derivatives, their synthesis and use |
| 01/28/2004 | EP1383741A2 Process for the preparation of benazepril |
| 01/28/2004 | EP1383526A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471401A Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/28/2004 | CN1136191C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 01/28/2004 | CN1135982C Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine deriratives |
| 01/28/2004 | CN1135969C Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water |
| 01/27/2004 | US6683079 Reverse transcriptase inhibitors |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/22/2004 | WO2004007451A1 Indole-3-sulphur derivatives |
| 01/22/2004 | WO2004006866A2 Antifungal therapeutic targets |
| 01/22/2004 | WO2004006854A2 Method for identification of biologically active agents |
| 01/22/2004 | WO2004006851A2 Mycoplasma gallisepticum formulation |
| 01/22/2004 | WO2004006831A2 Method and device for inducing biological processes by micro-organs |
| 01/22/2004 | WO2003092542A3 Injectable chondrocyte implant |
| 01/22/2004 | US20040014998 Process for the preparation of baccatin III derivatives |
| 01/22/2004 | US20040014976 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/22/2004 | US20040014951 Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A |
| 01/22/2004 | US20040014899 The method comprises administering to the patient a therapeutically effective amount of a salt of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer salt comprises the reaction product of crosslinked polymers, |
| 01/22/2004 | US20040014810 Schizophrenia; dyskinesias |
| 01/22/2004 | US20040014767 Central nervous system diosrders; antidepressants, anxiolytic agents, anxiolytic agents |
| 01/22/2004 | US20040014708 Composition comprising immunogenic microparticles |
| 01/22/2004 | US20040014100 Methods and compositions utilizing inteins to generate libraries of cyclic peptides in vivo |
| 01/22/2004 | US20040013691 Immunotoxin as a therapeutic agent and uses thereof |
| 01/22/2004 | US20040013616 Oral care products comprising calcium metasilicates |
| 01/22/2004 | CA2492662A1 Method for identification of biologically active agents |
| 01/22/2004 | CA2492445A1 Indole-3-sulphur derivatives |
| 01/21/2004 | EP1381358A1 Solid pharmaceutical composition comprising 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp |
| 01/21/2004 | EP1381352A1 Transdermal patch for administering fentanyl |
| 01/21/2004 | EP1381346A2 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 01/21/2004 | EP0999846B1 Phosphatidic acid-based immune modulator composition |
| 01/21/2004 | EP0941129B1 Process for the production of iodinated organic x-ray contrast agents |
| 01/21/2004 | CN1135112C Medicine for curing emmeniopathy and its preparation method |
| 01/20/2004 | US6680341 Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor |
| 01/20/2004 | US6680329 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants |
| 01/20/2004 | US6680074 Potent antiviral, antibacterial or antimycotic activity |
| 01/20/2004 | CA2258501C Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 01/15/2004 | WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | WO2004005250A1 Hmg-coa reductase inhibitors |
| 01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | WO2003088920A8 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | WO2003053350A3 Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 01/15/2004 | US20040009958 Inhibiting hyperproliferation of malignant or neoplastic cells in acute lymphobalstic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia and plasma cell dyscrasias. |
| 01/15/2004 | US20040009216 Administering liposomes comprising phospholipids and an aqueous layer, said liposomes having specified average diameter; treating various cardiovascular disorders, reducing cholesterol |
| 01/15/2004 | US20040009184 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 01/15/2004 | US20040009179 Mycoplasma gallisepticum formulation |
| 01/15/2004 | US20040009171 Methods for the treatment of carcinoma |
| 01/15/2004 | US20040009169 Administration of agents for the treatment of inflammation |
| 01/15/2004 | US20040009132 Stable cosmetic emulsion with polyamide gelling agent |
| 01/15/2004 | CA2492162A1 Hmg-coa reductase inhibitors |
| 01/15/2004 | CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/14/2004 | EP1380573A2 Isoquinolines and preparation thereof |
| 01/14/2004 | EP1380301A1 Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive |
| 01/14/2004 | EP1379203A1 Condom with an erectogenic composition |
| 01/14/2004 | EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468249A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/14/2004 | CN1468097A Compositions comprising modafinil compounds |
| 01/14/2004 | CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate |
| 01/14/2004 | CN1134434C Novel 2-heterocyclically substituted dihydropyrimidines |
| 01/14/2004 | CN1134432C Omeprazole sodium salt |
| 01/14/2004 | CN1134252C Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 01/13/2004 | US6677455 Potassium salt of S-omeprazole |
| 01/13/2004 | US6677358 NIDDM regimen |
| 01/13/2004 | US6677336 Substituted piperazine compounds |
| 01/13/2004 | US6676975 Chinese herbal composition for treating eczema and psoriasis |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/08/2004 | WO2004002957A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/08/2004 | WO2004002426A2 Identification of imprints on dosage forms |
| 01/08/2004 | WO2003090666A3 Glucocorticoid receptor protein crystals |
| 01/08/2004 | WO2003072051A3 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 01/08/2004 | WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 01/08/2004 | US20040005647 Comprises monocolnal antibody for diagnosis and treatment of cancer; antitumor agents; tumor imaging |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/08/2004 | CA2490189A1 Method, routines and system for identification of imprints on dosage forms |
| 01/08/2004 | CA2490138A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377227A1 Vessel sealing instrument |
| 01/07/2004 | EP0973505B1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/07/2004 | EP0935457B1 Preparation for the transport of an active substance across barriers |
| 01/07/2004 | EP0855900B1 A depilatory composition with improved rinsing properties |
| 01/07/2004 | EP0785775B1 Melt-extruded orally administrable opioid formulations |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466570A Crystalline and pure modafinil and process of preparing the same |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/07/2004 | CN1133414C Use of nanodispersions in cosmetic end formulations |
| 01/06/2004 | US6673833 As antitumor agent |
| 01/06/2004 | US6673810 Anticoagulants |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |
| 01/02/2004 | EP1372631A1 Method and formula for anti-tumor and anti-matastatic effect |